Anthony D Yang1, Daniel Brock Hewitt1,2, Eddie Blay1,3, Lindsey J Kreutzer1, Christopher M Quinn1, Kimberly A Cradock1,4, Vivek Prachand1,5, Karl Y Bilimoria1. 1. Illinois Surgical Quality Improvement Collaborative (ISQIC), Chicago, IL. 2. Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA. 3. Department of Surgery, Temple University Hospital, Philadelphia, PA. 4. Department of Surgery, Carle Foundation Hospital, Urbana, IL. 5. Department of Surgery, University of Chicago School of Medicine, Chicago, IL.
Abstract
OBJECTIVES: The aims of this study were to: (1) measure the rate of failure to provide defect-free postoperative venous thromboembolism (VTE) chemoprophylaxis, (2) identify reasons for failure to provide defect-free VTE chemoprophylaxis, and (3) examine patient- and hospital-level factors associated with failure. SUMMARY BACKGROUND DATA: Current VTE quality measures are inadequate. VTE outcome measures are invalidated for interhospital comparison by surveillance bias. VTE process measures (e.g., SCIP-VTE-2) do not comprehensively capture failures throughout patients' entire hospitalization. METHODS: We examined adherence to a novel VTE chemoprophylaxis process measure in patients who underwent colectomies over 18 months at 36 hospitals in a statewide surgical collaborative. This measure assessed comprehensive VTE chemoprophylaxis during each patient's entire hospitalization, including reasons why chemoprophylaxis was not given. Associations of patient and hospital characteristics with measure failure were examined. RESULTS: The SCIP-VTE-2 hospital-level quality measure identified failures of VTE chemoprophylaxis in 0% to 3% of patients. Conversely, the novel measure unmasked failure to provide defect-free chemoprophylaxis in 18% (736/4086) of colectomies. Reasons for failure included medication not ordered (30.4%), patient refusal (30.3%), incorrect dosage/frequency (8.2%), and patient off-unit (3.4%). Patients were less likely to fail the chemoprophylaxis process measure if treated at nonsafety net hospitals (OR 0.62, 95% CI 0.39-0.99, P = 0.045) or Magnet designated hospitals (OR 0.45, 95% CI 0.29-0.71, P = 0.001). CONCLUSIONS: In contrast to SCIP-VTE-2, our novel quality measure unmasked VTE chemoprophylaxis failures in 18% of colectomies. Most failures were due to patient refusals or ordering errors. Hospitals should focus improvement efforts on ensuring patients receive VTE prophylaxis throughout their entire hospitalization.
OBJECTIVES: The aims of this study were to: (1) measure the rate of failure to provide defect-free postoperative venous thromboembolism (VTE) chemoprophylaxis, (2) identify reasons for failure to provide defect-free VTE chemoprophylaxis, and (3) examine patient- and hospital-level factors associated with failure. SUMMARY BACKGROUND DATA: Current VTE quality measures are inadequate. VTE outcome measures are invalidated for interhospital comparison by surveillance bias. VTE process measures (e.g., SCIP-VTE-2) do not comprehensively capture failures throughout patients' entire hospitalization. METHODS: We examined adherence to a novel VTE chemoprophylaxis process measure in patients who underwent colectomies over 18 months at 36 hospitals in a statewide surgical collaborative. This measure assessed comprehensive VTE chemoprophylaxis during each patient's entire hospitalization, including reasons why chemoprophylaxis was not given. Associations of patient and hospital characteristics with measure failure were examined. RESULTS: The SCIP-VTE-2 hospital-level quality measure identified failures of VTE chemoprophylaxis in 0% to 3% of patients. Conversely, the novel measure unmasked failure to provide defect-free chemoprophylaxis in 18% (736/4086) of colectomies. Reasons for failure included medication not ordered (30.4%), patient refusal (30.3%), incorrect dosage/frequency (8.2%), and patient off-unit (3.4%). Patients were less likely to fail the chemoprophylaxis process measure if treated at nonsafety net hospitals (OR 0.62, 95% CI 0.39-0.99, P = 0.045) or Magnet designated hospitals (OR 0.45, 95% CI 0.29-0.71, P = 0.001). CONCLUSIONS: In contrast to SCIP-VTE-2, our novel quality measure unmasked VTE chemoprophylaxis failures in 18% of colectomies. Most failures were due to patient refusals or ordering errors. Hospitals should focus improvement efforts on ensuring patients receive VTE prophylaxis throughout their entire hospitalization.
Authors: Stacy Elder; Deborah B Hobson; Cynthia S Rand; Michael B Streiff; Elliott R Haut; Leigh E Efird; Peggy S Kraus; Christoph U Lehmann; Kenneth M Shermock Journal: J Patient Saf Date: 2016-06 Impact factor: 2.844
Authors: Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Mila H Ju; Jeanette W Chung; Christine V Kinnier; David J Bentrem; David M Mahvi; Clifford Y Ko; Karl Y Bilimoria Journal: Ann Surg Date: 2014-09 Impact factor: 12.969
Authors: Mark E Cohen; Clifford Y Ko; Karl Y Bilimoria; Lynn Zhou; Kristopher Huffman; Xue Wang; Yaoming Liu; Kari Kraemer; Xiangju Meng; Ryan Merkow; Warren Chow; Brian Matel; Karen Richards; Amy J Hart; Justin B Dimick; Bruce L Hall Journal: J Am Coll Surg Date: 2013-04-28 Impact factor: 6.113
Authors: John Fanikos; Leslie Ann Stevens; Matthew Labreche; Gregory Piazza; Elaine Catapane; Lena Novack; Samuel Z Goldhaber Journal: Am J Med Date: 2010-06 Impact factor: 4.965
Authors: Ravi Rajaram; Jeanette W Chung; Christine V Kinnier; Cynthia Barnard; Sanjay Mohanty; Emily S Pavey; Megan C McHugh; Karl Y Bilimoria Journal: JAMA Date: 2015-07-28 Impact factor: 56.272
Authors: Cary Jo R Schlick; Reiping Huang; Brian C Brajcich; Amy L Halverson; Anthony D Yang; Lindsey Kreutzer; Karl Y Bilimoria; Michael F McGee Journal: Dis Colon Rectum Date: 2022-07-05 Impact factor: 4.412
Authors: Jianlin Shi; John F Hurdle; Stacy A Johnson; Jeffrey P Ferraro; David E Skarda; Samuel R G Finlayson; Matthew H Samore; Brian T Bucher Journal: Surgery Date: 2021-06-03 Impact factor: 4.348
Authors: Rhami Khorfan; Lindsey Kreutzer; Remi Love; Cary Jo R Schlick; Matthew Chia; Karl Y Bilimoria; Anthony D Yang Journal: Ann Surg Date: 2021-04-01 Impact factor: 13.787